Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $56.10 | Total: $280.50 |
| 1 | 10 | $47.52 | Total: $475.20 |
| 1 | 25 | $40.26 | Total: $1,006.50 |
| 1 | 50 | $34.32 | Total: $1,716.00 |
| 1 | 100 | $29.70 | Total: $2,970.00 |
Overview
H3B-5942 belongs to a class of ER? antagonists referred to as selective estrogen receptor covalent antagonists (SERCA).
Chemical Properties
| Molecular Formula | C31H34N4O2 |
| Molecular Weight | 494.63 |
| CAS Numbers | 2052128-15-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCC(=C(c1ccc(OCCNCC=CC(=O)N(C)C)cc1)c1ccc2[nH]ncc2c1)c1ccccc1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Discovery of Selective Estrogen Receptor Covalent Antagonists [SERCAs] for the treatment of ERa[WT] and ERa[MUT] breast cancer.[J]. Cancer Discovery, 2018 CD-17-1229-.